Literature DB >> 14727044

[Endotoxins. Pathogenetic meaning of sepsis].

H Rensing1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14727044     DOI: 10.1007/s00101-003-0587-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  56 in total

Review 1.  Clinical implications of antibiotic-induced endotoxin release in septic shock.

Authors:  P M Lepper; T K Held; E M Schneider; E Bölke; H Gerlach; M Trautmann
Journal:  Intensive Care Med       Date:  2002-05-30       Impact factor: 17.440

2.  Jarisch-Herxheimer reaction in early syphilis treated with crystalline penicillin G.

Authors:  T W FARMER
Journal:  J Am Med Assoc       Date:  1948-10-16

Review 3.  Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.

Authors:  E A Kirsch; R P Barton; L Kitchen; B P Giroir
Journal:  Pediatr Infect Dis J       Date:  1996-11       Impact factor: 2.129

Review 4.  Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.

Authors:  S M Opal; R L Yu
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

5.  Differential antibiotic-induced endotoxin release in severe melioidosis.

Authors:  A J Simpson; S M Opal; B J Angus; J M Prins; J E Palardy; N A Parejo; W Chaowagul; N J White
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

6.  Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.

Authors:  D Fekade; K Knox; K Hussein; A Melka; D G Lalloo; R E Coxon; D A Warrell
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Nosocomial bloodstream infections in Finnish hospitals during 1999-2000.

Authors:  O Lyytikäinen; J Lumio; H Sarkkinen; E Kolho; A Kostiala; P Ruutu
Journal:  Clin Infect Dis       Date:  2002-06-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.